HCA vs SOLS · P/E 17, rev $75.60B vs P/E 71, rev $3.89B
HCA Holdings Inc (HCA) versus Solstice Advanced Materials, Inc (SOLS) — a side-by-side from cached financials, not a winner call.
HCA Holdings Inc (HCA) is a medical care facilities company listed on US.
Solstice Advanced Materials, Inc (SOLS) is a specialty chemicals company listed on NASDAQ.
Latest reported HCA revenue for 2025-12-31 was $75.60B. Net income was $6.78B. Revenue was up 7.1% from 2024-12-31 to 2025-12-31. HCA currently screens at market cap $91.01B and trailing P/E 16.8.
Latest reported SOLS revenue for 2025-12-31 was $3.89B. Net income was $237.0M. Revenue was up 3.1% from 2024-12-31 to 2025-12-31. SOLS currently screens at market cap $13.51B and trailing P/E 71.5.
HCA currently screens at market cap $91.01B and trailing P/E 16.8. SOLS currently screens at market cap $13.51B and trailing P/E 71.5.
Not investment advice. Open the HCA and SOLS stock pages for the full models.
Not investment advice.